Organization
Barcelona Institute for Global Health
7 clinical trials
Clinical trial
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield InterventionStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Adaptive Phase II/III SingleBlinded, Randomized, MultiCentre, ParallelGroup, Active Controlled, Superiority Study to Evaluate the Safety and Efficacy of a Single Day or 3day Single Dose of an ALBENDAZOLE IVERMECTIN Coformulation vs ALBENDAZOLE for the Treatment of SoilTransmitted Helminth Infections (Trichuris Trichiura, Hookworm, Strongyloides Stercoralis) in Paediatric and Young Adult PopulationStatus: Terminated, Estimated PCD: 2023-03-21
Clinical trial
A Phase III Cluster-randomized, Open-label, Clinical Trial to Study the Safety and Efficacy of Ivermectin Mass Drug Administration to Reduce Malaria Transmission in Two African SettingsStatus: Active (not recruiting), Estimated PCD: 2024-04-16
Clinical trial
Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra LeoneStatus: Recruiting, Estimated PCD: 2025-10-15
Clinical trial
Efficacy of Low Dose Acetylsalicylic Acid in Preventing Adverse Maternal and Perinatal Outcomes in SARS-CoV-2 Infected Pregnant WomenStatus: Active (not recruiting), Estimated PCD: 2024-06-09
Clinical trial
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic: A Multicentre, Double-Blinded Randomized Controlled TrialStatus: Completed, Estimated PCD: 2020-06-25
Clinical trial
Evaluation of the Safety and Efficacy of Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment of Malaria in HIV-infected Pregnant WomenStatus: Completed, Estimated PCD: 2022-07-19